| Issue Date | Title | Author(s) |
| 2018-01-01 | Dimerization of p15RS mediated by a leucine zipper–like motif is critical for its inhibitory role on Wnt signaling | Fan, X; Zhao, J; Ren, F; Wang, Y; Feng, Y; Ding, L; Zhao, L; Shang, Y; Li, J; Ni, J; Jia, B; Liu, Y; Chang, Z |
| 2018-12-10 | Lymphocyte-Specific Chromatin Accessibility Pre-determines Glucocorticoid Resistance in Acute Lymphoblastic Leukemia | Jing, D; Huang, Y; Liu, X; Sia, KCS; Zhang, JC; Tai, X; Wang, M; Toscan, CE; McCalmont, H; Evans, K; Mayoh, C; Poulos, RC; Span, M; Mi, J; Zhang, C; Wong, JWH; Beck, D; Pimanda, JE; Lock, RB |
| 2018-06-01 | Effect of glycated insulin on the blood-brain barrier permeability: An in vitro study | Shahriyary, L; Riazi, G; Lornejad, MR; Ghezlou, M; Bigdeli, B; Delavari, B; Mamashli, F; Abbasi, S; Davoodi, J; Saboury, AA |
| 2020-12 | Shwachman-Bodian-Diamond syndrome (SBDS) protein is a direct inhibitor of protein phosphatase 2A (PP2A) activity and overexpressed in acute myeloid leukaemia. | Dun, MD; Mannan, A; Rigby, CJ; Butler, S; Toop, HD; Beck, D; Connerty, P; Sillar, J; Kahl, RGS; Duchatel, RJ; Germon, Z; Faulkner, S; Chi, M; Skerrett-Byrne, D; Murray, HC; Flanagan, H; Almazi, JG; Hondermarck, H; Nixon, B; De Iuliis, G; Chamberlain, J; Alvaro, F; de Bock, CE; Morris, JC; Enjeti, AK; Verrills, NM |
| 2014-12-01 | Computational analysis of image-based drug profiling predicts synergistic drug combinations: Applications in triple-negative breast cancer | Brandl, MB; Pasquier, E; Li, F; Beck, D; Zhang, S; Zhao, H; Kavallaris, M; Wong, STC |
| 2020-06-10 | X-ray induced photodynamic therapy (PDT) with a mitochondria-targeted liposome delivery system. | Gu, X; Shen, C; Li, H; Goldys, EM; Deng, W |
| 2015-11-16 | Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Promotes Angiogenesis and Ischemia-Induced Neovascularization Via NADPH Oxidase 4 (NOX4) and Nitric Oxide-Dependent Mechanisms. | Di Bartolo, BA; Cartland, SP; Prado-Lourenco, L; Griffith, TS; Gentile, C; Ravindran, J; Azahri, NSM; Thai, T; Yeung, AWS; Thomas, SR; Kavurma, MM |
| 2013-09 | BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancer. | Stone, A; Cowley, MJ; Valdes-Mora, F; McCloy, RA; Sergio, CM; Gallego-Ortega, D; Caldon, CE; Ormandy, CJ; Biankin, AV; Gee, JMW; Nicholson, RI; Print, CG; Clark, SJ; Musgrove, EA |
| 2021-03-03 | A novel combination therapy targeting ubiquitin-specific protease 5 in MYCN-driven neuroblastoma | Cheung, BB; Kleynhans, A; Mittra, R; Kim, PY; Holien, JK; Nagy, Z; Ciampa, OC; Seneviratne, JA; Mayoh, C; Raipuria, M; Gadde, S; Massudi, H; Wong, IPL; Tan, O; Gong, A; Suryano, A; Diakiw, SM; Liu, B; Arndt, GM; Liu, T; Kumar, N; Sangfelt, O; Zhu, S; Norris, MD; Haber, M; Carter, DR; Parker, MW; Marshall, GM |
| 2015-03 | Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells. | Park, JH; Szemes, M; Vieira, GC; Melegh, Z; Malik, S; Heesom, KJ; Von Wallwitz-Freitas, L; Greenhough, A; Brown, KW; Zheng, YG; Catchpoole, D; Deery, MJ; Malik, K |
